Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-005215

VP and Chief Compliance Office gave up 1,186 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Herman James L VP and Chief Compliance Office 2024-03-23 Shares withheld for taxes −1,186 $1.81 $2,147 38,255 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Herman James L VP and Chief Compliance Office 2024-03-25 Grant or award · Options (right to buy) +4,000 $1.71 $6,840 16,000 D: show line 2 in the form
Loading xslF345X05/marketforms-65386.xml…